PDT Pharma is a specialist biopharmaceutical company at the forefront of Photodynamic Therapy (PDT). The Austrian-based firm is dedicated to developing and supplying photosensitiser-based treatments for a wide range of cancers, from precursors to metastatic disease. Their core mission is to provide a minimally invasive, highly effective therapeutic option that precisely targets malignant cells while preserving organ function. By collaborating with leading clinical partners worldwide, PDT Pharma works to establish its technology as a vital treatment modality in modern oncology, offering new hope to patients with difficult-to-treat cancers.